{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:28:11Z","timestamp":1792124891992,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.eclinm.2025.103543","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:48:13Z","timestamp":1760554093000},"page":"103543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Shorter or biomarker-guided antibiotic durations for common serious neonatal infections: a collection of non-inferiority meta-analyses"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5595-8289","authenticated-orcid":false,"given":"Sourabh","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9277-9108","authenticated-orcid":false,"given":"Nandkishor S.","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv Sajan","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1572-4453","authenticated-orcid":false,"given":"Rajendra Prasad","family":"Anne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4021-4114","authenticated-orcid":false,"given":"Monisha","family":"Rameshbabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supreet","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Kiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9938","key":"10.1016\/j.eclinm.2025.103543_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(14)60496-7","article-title":"Every Newborn: progress, priorities, and potential beyond survival","volume":"384","author":"Lawn","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103543_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/archdischild-2019-316816","article-title":"Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network","volume":"105","author":"Li","year":"2020","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103543_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myad010","article-title":"Neonatal invasive candidiasis in low- and middle-income countries: data from the NeoOBS study","volume":"61","author":"Cook","year":"2023","journal-title":"Med Mycol"},{"key":"10.1016\/j.eclinm.2025.103543_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/712150","article-title":"Choice and duration of antimicrobial therapy for neonatal sepsis and meningitis","volume":"2011","author":"Sivanandan","year":"2011","journal-title":"Int J Pediatr"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103543_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0032-1333413","article-title":"Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis","volume":"30","author":"Shane","year":"2013","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.eclinm.2025.103543_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.894005","article-title":"Practice summary of antimicrobial therapy for commonly encountered conditions in the neonatal intensive care unit: a Canadian perspective","volume":"10","author":"Ting","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.eclinm.2025.103543_bib7","series-title":"Red book: 2024-2027 Report of the Committee on Infectious Diseases. Serious Bacterial Infections Caused by Enterobacteriaceae","year":"2024"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103543_bib8","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S1473-3099(16)30205-5","article-title":"Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study","volume":"16","author":"Cantey","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103543_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/jpc.16647","article-title":"Efficacy of short-course antibiotics for culture-positive neonatal sepsis: a systematic review and meta-analysis","volume":"60","author":"Singh","year":"2024","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103543_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/tropej\/fmae002","article-title":"Efficacy and safety of short- vs. standard-course antibiotics for culture-negative neonatal sepsis: a systematic review and meta-analysis","volume":"70","author":"Devi","year":"2024","journal-title":"J Trop Pediatr"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2025.103543_bib11","article-title":"Efficacy of antibiotic regimens for meningitis in young infants aged 0\u201359 days: a systematic review","volume":"154","author":"Mathias","year":"2024","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103543_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/tropej\/fmv002","article-title":"Evaluation of duration of antibiotic therapy in neonatal bacterial meningitis: a randomized controlled trial","volume":"61","author":"Mathur","year":"2015","journal-title":"J Trop Pediatr"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103543_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/09732179231151758","article-title":"Comparison of efficacy of short-term versus conventional antibiotic regimen in treatment of neonatal pyogenic meningitis","volume":"37","author":"Mehta","year":"2023","journal-title":"J Neonatol"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103543_bib14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1542\/hpeds.2021-005877","article-title":"Treatment of UTIs in infants <2 months: a living systematic review","volume":"11","author":"Nama","year":"2021","journal-title":"Hosp Pediatr"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103543_bib15","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-052466","article-title":"Short intravenous antibiotic courses for urinary infections in young infants: a systematic review","volume":"149","author":"Hikmat","year":"2022","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103543_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/apa.16972","article-title":"Short course of intravenous antibiotics in the treatment of uncomplicated proven neonatal bacterial sepsis: a systematic review","volume":"113","author":"Aljarbou","year":"2024","journal-title":"Acta Paediatr"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103543_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72088-2","article-title":"Assessment of non-inferiority with meta-analysis: example of hypofractionated radiation therapy in breast and prostate cancer","volume":"10","author":"Trone","year":"2020","journal-title":"Sci Rep"},{"issue":"14","key":"10.1016\/j.eclinm.2025.103543_bib18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJMra1510063","article-title":"Challenges in the design and interpretation of noninferiority trials","volume":"377","author":"Mauri","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2025.103543_bib19","series-title":"AHRQ Methods for Effective Health Care. Assessing Equivalence and Noninferiority","author":"Treadwell","year":"2012"},{"key":"10.1016\/j.eclinm.2025.103543_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jclinepi.2020.05.034","article-title":"Meta-analysis of noninferiority and equivalence trials: ignoring trial design leads to differing and possibly misleading conclusions","volume":"127","author":"Acuna","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2025.103543_bib21","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.eclinm.2025.103543_bib22","author":"Wells"},{"key":"10.1016\/j.eclinm.2025.103543_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.13105\/wjma.v5.i4.80","article-title":"Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale","volume":"5","author":"Luchini","year":"2017","journal-title":"World J Meta-Anal"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103543_bib24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/SLA.0000000000003072","article-title":"Laparoscopic versus open resection for rectal cancer: a noninferiority meta-analysis of quality of surgical resection outcomes","volume":"269","author":"Acuna","year":"2019","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103543_bib25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/INF.0000000000003314","article-title":"Duration of antibiotic therapy in neonatal Gram-negative bacterial sepsis-10 days versus 14 days: a randomized controlled trial","volume":"41","author":"Fursule","year":"2022","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103543_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/tropej\/fmad036","article-title":"Ten- vs. 14-day antibiotic therapy for culture-positive neonatal sepsis","volume":"69","author":"Islam","year":"2023","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.eclinm.2025.103543_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2024-328232","article-title":"Seven-day versus 14-day antibiotic course for culture-proven neonatal sepsis: a multicentre randomised non-inferiority trial in a low and middle-income country","author":"Dutta","year":"2025","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"10097","key":"10.1016\/j.eclinm.2025.103543_bib28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(17)31444-7","article-title":"Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)","volume":"390","author":"Stocker","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103543_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000241296","article-title":"Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial","volume":"97","author":"Stocker","year":"2010","journal-title":"Neonatology"},{"key":"10.1016\/j.eclinm.2025.103543_bib30","series-title":"NERDCAT, A Clinician\u2019s Guide to Appraising Randomized Controlled Trials, Systematic Reviews and Meta-Analyses. Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License","article-title":"Non-inferiority trials: was the intervention compared to see if it is \u201cno worse\u201d than an established therapy?","author":"Turgeon","year":"2022"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103543_bib31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamainternmed.2023.0918","article-title":"Stakeholder perspectives on minimum clinically important difference and noninferiority margin for hospital-free days to assess interventions","volume":"183","author":"Auriemma","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eclinm.2025.103543_bib32","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.5","author":"Higgins","year":"2024"},{"key":"10.1016\/j.eclinm.2025.103543_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103543_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103543_bib35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/tropej\/fml054","article-title":"Randomized controlled trial of 7-day vs. 14-day antibiotics for neonatal sepsis","volume":"52","author":"Chowdhary","year":"2006","journal-title":"J Trop Pediatr"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103543_bib36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/tropej\/fmq012","article-title":"Ten days vs. 14 days antibiotic therapy in culture-proven neonatal sepsis","volume":"56","author":"Gathwala","year":"2010","journal-title":"J Trop Pediatr"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103543_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/jpc.13518","article-title":"Seven versus 10 days antibiotic therapy for culture-proven neonatal sepsis: a randomised controlled trial","volume":"53","author":"Rohatgi","year":"2017","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103543_bib38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12098-021-03794-6","article-title":"Ten versus 14 days of antibiotic therapy in culture-proven neonatal sepsis: a randomized, controlled trial","volume":"89","author":"Reddy","year":"2022","journal-title":"Indian J Pediatr"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103543_bib39","first-page":"352","article-title":"C-Reactive protein as a single useful parameter for discontinuation of antibiotic treatment in Thai neonates with clinical sepsis","volume":"98","author":"Numbenjapon","year":"2015","journal-title":"J Med Assoc Thai"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103543_bib43","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s12098-018-2708-y","article-title":"Comparison of four days versus seven days duration of antibiotic therapy for neonatal pneumonia: a randomized controlled trial","volume":"85","author":"Mathur","year":"2018","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.eclinm.2025.103543_bib41","series-title":"Role of Serial C-reactive Protein for Suspected Neonatal Sepsis: A Randomised Control Trial [Master's thesis]","author":"Ahamed","year":"2016"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103543_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13312-011-0019-8","article-title":"Short course versus 7-day course of intravenous antibiotics for probable neonatal septicemia: a pilot, open-label, randomized controlled trial","volume":"48","author":"Saini","year":"2011","journal-title":"Indian Pediatr"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103543_bib45","first-page":"673","article-title":"3-day versus 5-day course of intravenous antibiotics for suspected early onset neonatal sepsis: a randomized controlled trial","volume":"24","author":"Pasha","year":"2014","journal-title":"Iran J Pediatr"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103543_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s13054-021-03789-x","article-title":"Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates","volume":"25","author":"Geraerds","year":"2021","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103543_bib46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.jp.7200416","article-title":"Neonatal pneumonia: comparison of 4 vs 7 days of antibiotic therapy in term and near-term infants","volume":"20","author":"Engle","year":"2000","journal-title":"J Perinatol"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103543_bib40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1542\/peds.99.2.216","article-title":"C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection","volume":"99","author":"Ehl","year":"1997","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103543_bib47","first-page":"151","article-title":"3 days vs. 7 days course of intravenous antibiotics for probable neonatal sepsis","volume":"4","author":"Prashanth","year":"2017","journal-title":"Int J Pediatr Res"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103543_bib48","first-page":"263","article-title":"Comparison of short course of antibiotic therapy versus 7-day course in preterm infants with probable sepsis without meningitis","volume":"4","author":"Bansal","year":"2016","journal-title":"Int J Sci Study"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103543_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/pch\/pxz164","article-title":"Transition to oral antibiotic therapy for pyelonephritis in children under 60 days of age: an observational retrospective cohort study","volume":"26","author":"Lessard","year":"2020","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.eclinm.2025.103543_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fped.2020.00237","article-title":"Management of febrile urinary tract infection with or without bacteraemia in children: a French case-control retrospective study","volume":"8","author":"Goeller","year":"2020","journal-title":"Front Pediatr"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103543_bib51","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1542\/hpeds.2020-0178","article-title":"Urinary tract infection in young infants: practice patterns in evaluation and treatment","volume":"10","author":"Swartz","year":"2020","journal-title":"Hosp Pediatr"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103543_bib52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1542\/hpeds.2019-0325","article-title":"Relationship between clinical factors and duration of IV antibiotic treatment in neonatal UTI","volume":"10","author":"Marsh","year":"2020","journal-title":"Hosp Pediatr"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103543_bib53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/INF.0000000000002515","article-title":"Outcomes of empirical antimicrobial therapy for pediatric community-onset febrile urinary tract infection in the era of increasing antimicrobial resistance","volume":"39","author":"Kantamalee","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103543_bib54","first-page":"316","article-title":"Association between antibiotic duration and recurrence of urinary tract infection in the neonatal critical care unit","volume":"29","author":"Van","year":"2024","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103543_bib55","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00381-023-06240-4","article-title":"Systematic review and meta-analysis of intraventricular antibiotics for neonatal meningitis and ventriculitis","volume":"40","author":"Valdivia","year":"2024","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.eclinm.2025.103543_bib56","series-title":"Nelson Textbook of Pediatrics","author":"Kliegman","year":"2024"},{"key":"10.1016\/j.eclinm.2025.103543_bib57","series-title":"Feigin and Cherry\u2019s Textbook of Pediatric Infectious Diseases","author":"Cherry","year":"2013"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103543_bib58","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/s41416-022-01937-w","article-title":"Interpreting the results of noninferiority trials\u2014a review","volume":"127","author":"Cuzick","year":"2022","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103543_bib59","first-page":"181","article-title":"Duration of antibiotic therapy for common infections","volume":"6","author":"Grant","year":"2021","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103543_bib60","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMoa2404991","article-title":"Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections","volume":"392","author":"Daneman","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103543_bib61","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/ph17030339","article-title":"Shorter and longer antibiotic durations for respiratory infections: to fight antimicrobial resistance-A retrospective cross-sectional study in a secondary care setting in the UK","volume":"17","author":"Abdelsalam Elshenawy","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103543_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M18-3640","article-title":"Excess antibiotic treatment duration and adverse events in patients hospitalized with pneumonia: a multihospital cohort study","volume":"171","author":"Vaughn","year":"2019","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2025.103543_bib63","article-title":"Efficacy of antibiotic regimens for pneumonia in young infants aged 0\u201359 days: a systematic review","volume":"154","author":"North","year":"2024","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2025.103543_bib64","article-title":"Efficacy of antibiotic regimens for sepsis or possible serious bacterial infection in young infants aged 0 to 59 days: a systematic review and meta-analysis","volume":"154","author":"North","year":"2024","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103543_bib65","doi-asserted-by":"crossref","DOI":"10.5662\/wjm.v15.i1.97814","article-title":"Beyond statistical significance: embracing minimal clinically important difference for better patient care","volume":"15","author":"Jeyaraman","year":"2025","journal-title":"World J Methodol"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103543_bib66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/sim.2528","article-title":"Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events","volume":"26","author":"Bradburn","year":"2007","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103543_bib67","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-058813","article-title":"Late-onset sepsis among very preterm infants","volume":"150","author":"Flannery","year":"2022","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103543_bib68","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.0593","article-title":"Early-onset neonatal sepsis 2015 to 2017, the rise of Escherichia coli, and the need for novel prevention strategies","volume":"174","author":"Stoll","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.eclinm.2025.103543_bib69","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6626983","article-title":"A systemic review and meta-analysis of the leading pathogens causing neonatal sepsis in developing countries","volume":"2021","author":"Zelellw","year":"2021","journal-title":"Biomed Res Int"},{"issue":"Suppl 7","key":"10.1016\/j.eclinm.2025.103543_bib70","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID\u2217 guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp","volume":"18","author":"Hope","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103543_bib71","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103543_bib72","first-page":"158","article-title":"Recommendations for the management of candidemia in neonates in Latin America. Latin America Invasive Mycosis Network","volume":"30","author":"Santolaya","year":"2013","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.eclinm.2025.103543_bib73","series-title":"Australasian Guidelines for Antifungal Therapy in Neonates and Children With Proven, Probable and Suspected Invasive Fungal Infections","author":"Blyth","year":"2007"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103543_bib74","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.2006-2931","article-title":"Antifungal therapy in children with invasive fungal infections: a systematic review","volume":"119","author":"Blyth","year":"2007","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103543_bib75","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/myc.12268","article-title":"Invasive candidiasis and candidaemia in neonates and children: update on current guidelines","volume":"58","author":"Tragiannidis","year":"2015","journal-title":"Mycoses"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103543_bib76","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/313749","article-title":"Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America","volume":"30","author":"Rex","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103543_bib77","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103543_bib78","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10.1016\/j.eclinm.2025.103543_bib79","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025004766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025004766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T05:32:04Z","timestamp":1769059924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025004766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":79,"alternative-id":["S2589537025004766"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103543","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shorter or biomarker-guided antibiotic durations for common serious neonatal infections: a collection of non-inferiority meta-analyses","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103543","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103543"}}